European Commission expands Merck Ervebo indication to include children 1 year of age and older Ruchika Sharma9 Sept 2023 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved an expanded...
Natco Pharma, others sued in US for generic cancer drug Ruchika Sharma8 Sept 2023 4:13 PM ISTHyderabad: Natco Pharma on Friday said the company and other drug makers have been named defendants in an antitrust lawsuit regarding a generic...
52 percent Indian families have had 1 member face unknown side effects from medicine: Report MD Bureau8 Sept 2023 1:45 PM ISTNew Delhi: A whopping 52 per cent Indian families have had at least one member face unknown side effects from medicine, according to a report on...
Eli Lilly diabetes drug Mounjaro won UK watchdog backing: Bloomberg Ruchika Sharma8 Sept 2023 12:34 PM ISTBritain: Eli Lilly's drug Mounjaro has won the backing of Britain's drug cost-effectiveness watchdog as a diabetes treatment, Bloomberg News reported...
Johnson & Johnson to halt hypertension drug Macitentan study Ruchika Sharma8 Sept 2023 11:43 AM ISTThe study was deemed "futile" and failed to improve exercise capacity in a broad population including inoperable patients compared to a placebo, J&J...
Aurobindo Pharma gets USFDA EIR for Telangana facility Ruchika Sharma8 Sept 2023 10:30 AM ISTHyderabad: Aurobindo Pharma has announced that the company has received an Establishment Inspection Report (EIR) from United States Food and Drug...
Boston Scientific gets USFDA nod for latest generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device Ruchika Sharma7 Sept 2023 3:30 PM ISTThe latest WATCHMAN FLX Pro device is enhanced with a coating designed to reduce device-related thrombus and enable faster, controlled healing and...
IndiaRF to acquire Ind-Swift Labs API, CRAMS business for Rs 1650 crores Ruchika Sharma7 Sept 2023 2:30 PM ISTMumbai: The Board of Directors of Ind-Swift Laboratories Limited (“IndSwift”) have approved a business transfer of its active pharmaceutical...
Bristol Myers Squibb accused of illegal tactics to keep blood cancer drug Pomalyst monopoly in lawsuit Ruchika Sharma7 Sept 2023 1:30 PM ISTBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on...
Biocon Biologics completes integration of acquired biosimilars business from Viatris in North America Ruchika Sharma7 Sept 2023 12:16 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the Company has completed the integration of the acquired ...
Lupin, Mark Cuban Cost Plus Drug Company and COPD Foundation collaborate to expand access to medication for COPD patients Ruchika Sharma7 Sept 2023 11:10 AM ISTMumbai: Global pharma major Lupin Limited has forged a unique collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) and the COPD...
Cipla Buyout Battle: Dr Reddys, Bain Capital to team up for joint bid? Drugmaker issues statement Farhat Nasim6 Sept 2023 3:36 PM ISTNew Delhi: The buyout battle for 33.47 percent promoter stake in Cipla, owned by the Hamied family has intensified as US-based private equity...
